Correlation Between Acumen Pharmaceuticals and Four Leaf

Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Four Leaf at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Four Leaf into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acumen Pharmaceuticals and Four Leaf Acquisition, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Four Leaf and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Four Leaf. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Four Leaf.

Diversification Opportunities for Acumen Pharmaceuticals and Four Leaf

-0.76

Correlation Coefficient

Acumen Pharmaceuticals  Four Leaf

Pay attention - limited upside

The 3 months correlation between Acumen and Four is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Four Leaf Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Four Leaf Acquisition and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Four Leaf. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Four Leaf Acquisition has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Four Leaf go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and Four Leaf

If you would invest  1,104  in Four Leaf Acquisition on October 12, 2024 and sell it today you would earn a total of  0.00  from holding Four Leaf Acquisition or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Acumen Pharmaceuticals  vs.  Four Leaf Acquisition

Acumen Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Four Leaf Acquisition

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Four Leaf Acquisition are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable essential indicators, Four Leaf is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Acumen Pharmaceuticals and Four Leaf

The main advantage of trading using opposite Acumen Pharmaceuticals and Four Leaf positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Four Leaf can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Four Leaf will offset losses from the drop in Four Leaf's long position.

The idea behind Acumen Pharmaceuticals and Four Leaf Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.